To evaluate neutralizing antibody titers against the reference WA1/2020 isolate of SARS-CoV-2 along with omicron subvariants BA.1, BA.2, BA.2.12.1, and BA.4 or BA.5 in vaccinated /boosted and infected
The binding kinetics of these mAbs were further assessed by BLI assays, and equilibrium constant (KD) values were calculated. BLI, bio-layer interferometry; mAb, monoclonal antibody; NAb, neutralizing
Enveloped viruses co-opt host glycosylation pathways to decorate their surface proteins. As viruses evolve, emerging strains can modify their glycosylation patterns to influence host interactions and
Human immunodeficiency virus (HIV-1) envelope glycoprotein subunits, such as the gp120 exterior glycoprotein, typically elicit antibodies that neutralize T-cell-line-adapted (TCLA), but not primary, c